NOVN
E584146
NOVN is the stock ticker symbol for Novartis, a major Swiss multinational pharmaceutical company known for developing and manufacturing innovative medicines.
Observed surface forms (1)
| Surface form | Occurrences |
|---|---|
| Novartis | 0 |
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
Multinational corporation
ⓘ
Pharmaceutical company ⓘ |
| businessModel | Research-based pharmaceutical manufacturer ⓘ |
| country | Switzerland ⓘ |
| currencyOfListing | Swiss franc NERFINISHED ⓘ |
| employs | Tens of thousands of people worldwide ⓘ |
| fieldOfWork |
Cardiovascular medicine
ⓘ
Cell therapy ⓘ Clinical research ⓘ Drug discovery ⓘ Gene therapy ⓘ Immunology ⓘ Neuroscience ⓘ Oncology ⓘ |
| foundedBy |
Ciba-Geigy
NERFINISHED
ⓘ
Sandoz NERFINISHED ⓘ |
| hasBrand |
Novartis Pharmaceuticals
NERFINISHED
ⓘ
Sandoz NERFINISHED ⓘ |
| hasResearchCenter |
Basel, Switzerland
NERFINISHED
ⓘ
Cambridge, Massachusetts, United States NERFINISHED ⓘ |
| hasSubsidiary |
Alcon
NERFINISHED
ⓘ
Novartis Oncology NERFINISHED ⓘ Sandoz NERFINISHED ⓘ |
| headquartersLocation | Basel, Switzerland ⓘ |
| inception | 1996 ⓘ |
| industry |
Biotechnology
ⓘ
Healthcare ⓘ Pharmaceuticals ⓘ |
| ISIN | CH0012005267 ⓘ |
| legalForm | Aktiengesellschaft ⓘ |
| listedOn | SIX Swiss Exchange NERFINISHED ⓘ |
| notableProduct |
Cosentyx
NERFINISHED
ⓘ
Entresto NERFINISHED ⓘ Gleevec NERFINISHED ⓘ Kymriah NERFINISHED ⓘ Tasigna NERFINISHED ⓘ Zolgensma NERFINISHED ⓘ |
| productType |
Biosimilars
ⓘ
Generic medicines ⓘ Ophthalmic products ⓘ Prescription medicines ⓘ Vaccines ⓘ |
| scopeOfOperations | Global ⓘ |
| sector | Healthcare ⓘ |
| stockExchange | SIX Swiss Exchange NERFINISHED ⓘ |
| stockTicker | NOVN NERFINISHED ⓘ |
| website | https://www.novartis.com ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.